PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
Publication
, Journal Article
Kwee, RM; Marcus, C; Sheikhbahaei, S; Subramaniam, RM
Published in: PET Clin
April 2015
PET with fluorodeoxyglucose F 18/computed tomography ((18)F-FDG PET/CT) has evolved into an indispensable imaging technique in the management of patients with esophageal cancer. Staging with (18)F-FDG PET/CT is strongly associated with overall survival and certain (18)F-FDG PET/CT parameters predict patient survival. Current evidence supporting the validity of the use of (18)F-FDG PET/CT in the tumor delineation process for radiation treatment planning in patients with esophageal cancer is still limited. It is useful in determining treatment response after neoadjuvant therapy and thereby has an impact on management. (18)F-FDG PET/CT plays a role in the diagnosis of recurrent disease in patients with a background of clinical suspicion.
Duke Scholars
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
April 2015
Volume
10
Issue
2
Start / End Page
197 / 205
Location
United States
Related Subject Headings
- Treatment Outcome
- Tomography, X-Ray Computed
- Radiopharmaceuticals
- Radiography, Interventional
- Positron-Emission Tomography
- Patient Outcome Assessment
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
Kwee, R. M., Marcus, C., Sheikhbahaei, S., & Subramaniam, R. M. (2015). PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer. PET Clin, 10(2), 197–205. https://doi.org/10.1016/j.cpet.2014.12.003
Kwee, Robert M., Charles Marcus, Sara Sheikhbahaei, and Rathan M. Subramaniam. “PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.” PET Clin 10, no. 2 (April 2015): 197–205. https://doi.org/10.1016/j.cpet.2014.12.003.
Kwee RM, Marcus C, Sheikhbahaei S, Subramaniam RM. PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer. PET Clin. 2015 Apr;10(2):197–205.
Kwee, Robert M., et al. “PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.” PET Clin, vol. 10, no. 2, Apr. 2015, pp. 197–205. Pubmed, doi:10.1016/j.cpet.2014.12.003.
Kwee RM, Marcus C, Sheikhbahaei S, Subramaniam RM. PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer. PET Clin. 2015 Apr;10(2):197–205.
Published In
PET Clin
DOI
EISSN
1879-9809
Publication Date
April 2015
Volume
10
Issue
2
Start / End Page
197 / 205
Location
United States
Related Subject Headings
- Treatment Outcome
- Tomography, X-Ray Computed
- Radiopharmaceuticals
- Radiography, Interventional
- Positron-Emission Tomography
- Patient Outcome Assessment
- Nuclear Medicine & Medical Imaging
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy